|
The state of play on the proposal for a directive of the European Parliament and of the Council amending Directive 2013/34/EU as regards disclosure of income tax information by certain undertakings and branches (2016/0107(COD)), known as public country-by-country reporting |
|
Against
|
|
The draft Commission regulation amending Regulation (EU) No 546/2011 as regards the assessment of the impact of plant protection products on honeybees |
|
Abstention
|
|
2020 general budget: all sections |
|
Against
|
|
2017 discharge: European Asylum Support Office (EASO) |
|
For
|
|
2017 discharge: EU general budget, European Council and Council |
|
For
|
|
The 2021-2027 multiannual financial framework and own resources: time to meet citizens' expectations |
|
Against
|
|
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MZHG0JG (SYN-ØØØJG-2), pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council |
|
Against
|
|
The draft Commission implementing decision authorising the placing on the market of products containing, consisting of or produced from genetically modified maize MON 89034 × 1507 × MON 88017 × 59122 × DAS-40278-9 and genetically modified maize combining two, three or four of the single events MON 89034, 1507, MON 88017, 59122 and DAS-40278-9 pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council |
|
Against
|
|
The draft Commission implementing decision renewing the authorisation for the placing on the market of products containing, consisting of or produced from genetically modified soybean A2704-12 (ACS-GMØØ5-3) pursuant to Regulation (EC) No 1829/2003 of the European Parliament and of the Council |
|
Against
|
|
The draft Commission implementing regulation amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, beta-cyfluthrin, bifenox, chlorotoluron, clofentezine, clomazone, cypermethrin, daminozide, deltamethrin, dicamba, difenoconazole, diflubenzuron, diflufenican, fenoxaprop-P, fenpropidin, fludioxonil, flufenacet, fosthiazate, indoxacarb, lenacil, MCPA, MCPB, nicosulfuron, picloram, prosulfocarb, pyriproxyfen, thiophanate-methyl, triflusulfuron and tritosulfuron |
|
Abstention
|
|
Commission Implementing Regulation (EU) 2019/707 of 7 May 2019 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances alpha-cypermethrin, beflubutamid, benalaxyl, benthiavalicarb, bifenazate, boscalid, bromoxynil, captan, cyazofamid, desmedipham, dimethoate, dimethomorph, diuron, ethephon, etoxazole, famoxadone, fenamiphos, flumioxazine, fluoxastrobin, folpet, foramsulfuron, formetanate, metalaxyl-m, methiocarb, metribuzin, milbemectin, Paecilomyces lilacinus strain 251, phenmedipham, phosmet, pirimiphos-methyl, propamocarb, prothioconazole, s-metolachlor and tebuconazole |
|
Abstention
|
|
Employment and social policies of the euro area |
|
Abstention
|
|
Foreign electoral interference and disinformation in national and European democratic processes |
|
Against
|
|
Flexibility Instrument: adjustments to the amounts mobilised for 2019 to be used for migration, refugee inflows and security threats |
|
For
|
|
Amending budget 4/2019: reduction of commitment and payment appropriations in line with updated needs of expenditure and update of revenue (own resources) |
|
Against
|
|
The importance of European remembrance for the future of Europe |
|
Against
|
|
Iran, notably the situation of women’s rights defenders and imprisoned EU dual nationals |
|
Abstention
|
|
The state of implementation of the Union’s anti-money laundering legislation |
|
Abstention
|
|
The state of play of the UK’s withdrawal from the European Union |
|
Against
|
|
Amending budget 2/2019: Horizon 2020 and Erasmus+ |
|
Against
|
|
The situation in Venezuela |
|
Abstention
|